Author(s):
Pavel Osmancik
Added:
4 years ago
Dr Pavel Osmancik (University Hospital Kralovske Vinohrady, Prague, CZ) discuses 'Long-term follow-up of the PRAGUE-12 study and the five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation' at HRS 2019.
1. Can you tell us about the Prague-12 Study and why was it initiated?
2. What is the design of the trial?
3. What are…
View more
Job title: Professor
DrKazuhiro Yamamoto is a member of the editorial board for theJournal of Asian Pacific Society of Cardiology,published by Radcliffe Cardiology on behalf of the Asian Pacific Society of Cardiology.
View more
Prof Reza Wakili is the head of Arrhythmia Service and Electrophysiology Section West German Heart and Vascular Center University Hospital Essen, Germany. Prof Wakili specialises in arrhythmias.
View more
Author(s):
Anthony C Li,
Amit Kaura,
Nicholas Sunderland,et al
Added:
3 years ago
Since the 1990s, the publication of several large randomised controlled trials (RCTs) have established the efficacy of implantable cardioverter defibrillator (ICD) therapy in reducing the risk of sudden cardiac death (SCD) in high-risk patients. Collectively these trials have demonstrated a significant all-cause mortality reduction compared with medical therapy alone, for both the primary and…
View more